- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-3-3-1-1-9-1-1-mer
- Ligands
- 3 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 5 x MG: MAGNESIUM ION(Non-covalent)
MG.2: 2 residues within 4Å:- Chain B: T.179
- Ligands: ATP.1
1 PLIP interactions:1 interactions with chain B- Metal complexes: B:T.179
MG.4: 4 residues within 4Å:- Chain C: T.179, Q.211, D.272
- Ligands: ATP.3
1 PLIP interactions:1 interactions with chain C- Metal complexes: C:T.179
MG.6: 2 residues within 4Å:- Chain D: T.179
- Ligands: ATP.5
1 PLIP interactions:1 interactions with chain D- Metal complexes: D:T.179
MG.8: 4 residues within 4Å:- Chain E: T.178, E.203, R.204
- Ligands: ADP.7
1 PLIP interactions:1 interactions with chain E- Metal complexes: E:T.178
MG.10: 5 residues within 4Å:- Chain G: T.178, E.203, R.204, E.207
- Ligands: ADP.9
1 PLIP interactions:1 interactions with chain G- Metal complexes: G:T.178
- 2 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
ADP.7: 16 residues within 4Å:- Chain D: V.374, S.375, R.376
- Chain E: G.174, V.175, G.176, K.177, T.178, V.179, F.349, F.354, M.427, A.430, F.433, T.434
- Ligands: MG.8
13 PLIP interactions:10 interactions with chain E, 3 interactions with chain D- Hydrogen bonds: E:G.174, E:V.175, E:G.176, E:G.176, E:K.177, E:T.178, E:V.179, D:S.375
- Salt bridges: E:K.177, D:R.376, D:R.376
- pi-Stacking: E:F.354, E:F.354
ADP.9: 18 residues within 4Å:- Chain C: V.374, R.376
- Chain G: G.172, A.173, G.174, V.175, G.176, K.177, T.178, V.179, R.204, E.207, F.349, F.354, M.427, A.430, F.433
- Ligands: MG.10
14 PLIP interactions:13 interactions with chain G, 1 interactions with chain C- Hydrogen bonds: G:G.172, G:G.172, G:G.174, G:V.175, G:G.176, G:K.177, G:T.178, G:T.178, G:V.179, G:R.204
- Salt bridges: G:K.177, C:R.376
- pi-Stacking: G:F.354, G:F.354
- 7 x BQ1: Bedaquiline(Non-covalent)
BQ1.11: 12 residues within 4Å:- Chain A: L.168, P.170, I.171, V.174
- Chain J: E.61, A.62, Y.64, F.65, L.68
- Chain K: A.62, A.63, I.66
9 PLIP interactions:2 interactions with chain A, 6 interactions with chain J, 1 interactions with chain K- Hydrophobic interactions: A:P.170, A:V.174, J:E.61, J:F.65, J:F.65, J:F.65, J:L.68, K:I.66
- Salt bridges: J:E.61
BQ1.12: 11 residues within 4Å:- Chain A: I.215, W.216, F.219
- Chain M: E.61, A.62, Y.64, F.65, L.68
- Chain N: A.62, A.63, I.66
11 PLIP interactions:4 interactions with chain A, 6 interactions with chain M, 1 interactions with chain N- Hydrophobic interactions: A:I.215, A:I.215, A:F.219, A:F.219, M:E.61, M:F.65, M:F.65, M:F.65, M:L.68, N:I.66
- Salt bridges: M:E.61
BQ1.13: 8 residues within 4Å:- Chain N: G.58, E.61, A.62, Y.64, F.65
- Chain O: A.62, A.63, I.66
5 PLIP interactions:1 interactions with chain O, 4 interactions with chain N- Hydrophobic interactions: O:I.66, N:E.61, N:F.65, N:F.65
- Salt bridges: N:E.61
BQ1.14: 8 residues within 4Å:- Chain O: G.58, E.61, A.62, Y.64, F.65
- Chain P: A.62, A.63, I.66
5 PLIP interactions:4 interactions with chain O, 1 interactions with chain P- Hydrophobic interactions: O:E.61, O:F.65, O:F.65, P:I.66
- Salt bridges: O:E.61
BQ1.15: 9 residues within 4Å:- Chain P: G.58, E.61, A.62, Y.64, F.65, L.68
- Chain Q: A.62, A.63, I.66
4 PLIP interactions:1 interactions with chain Q, 3 interactions with chain P- Hydrophobic interactions: Q:I.66, P:F.65, P:L.68
- Salt bridges: P:E.61
BQ1.16: 8 residues within 4Å:- Chain Q: E.61, A.62, Y.64, F.65
- Chain R: A.62, A.63, I.66
- Ligands: BQ1.17
4 PLIP interactions:3 interactions with chain Q, 1 interactions with chain R- Hydrophobic interactions: Q:F.65, Q:F.65, R:I.66
- Salt bridges: Q:E.61
BQ1.17: 10 residues within 4Å:- Chain J: A.62, A.63, I.66
- Chain R: G.58, E.61, A.62, Y.64, F.65, L.68
- Ligands: BQ1.16
7 PLIP interactions:6 interactions with chain R, 1 interactions with chain J- Hydrophobic interactions: R:A.62, R:F.65, R:F.65, R:F.65, R:L.68, J:I.66
- Salt bridges: R:E.61
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, Y. et al., Inhibition of M. tuberculosis and human ATP synthase by BDQ and TBAJ-587. Nature (2024)
- Release Date
- 2024-05-22
- Peptides
- ATP synthase subunit a: A
ATP synthase subunit alpha: BCD
ATP synthase subunit beta: EFG
ATP synthase gamma chain: H
ATP synthase epsilon chain: I
ATP synthase subunit c: JKLMNOPQR
ATP synthase subunit b: S
Multifunctional fusion protein: T - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
aB
AC
BD
CE
DF
EG
FH
GI
HJ
1K
2L
3M
4N
5O
6P
7Q
8R
9S
bT
d - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-3-3-1-1-9-1-1-mer
- Ligands
- 3 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 5 x MG: MAGNESIUM ION(Non-covalent)
- 2 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 7 x BQ1: Bedaquiline(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, Y. et al., Inhibition of M. tuberculosis and human ATP synthase by BDQ and TBAJ-587. Nature (2024)
- Release Date
- 2024-05-22
- Peptides
- ATP synthase subunit a: A
ATP synthase subunit alpha: BCD
ATP synthase subunit beta: EFG
ATP synthase gamma chain: H
ATP synthase epsilon chain: I
ATP synthase subunit c: JKLMNOPQR
ATP synthase subunit b: S
Multifunctional fusion protein: T - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
aB
AC
BD
CE
DF
EG
FH
GI
HJ
1K
2L
3M
4N
5O
6P
7Q
8R
9S
bT
d - Membrane
-
We predict this structure to be a membrane protein.